Atrazine has been extensively used in China’s agricultural production for a long time and the potential risks to the environment have received widespread attention. The purpose of this study was to examine the effect of the continuous application of atrazine on soil herbicide residues, soil enzyme activity, and microbial community structure, as well as to provide a theoretical reference for the appropriate application of atrazine and the improvement of soil. Previous studies have focused on the effects of atrazine on soil microorganisms, but the experiments used higher doses than recommended. To reveal the actual effects of atrazine on soil microorganisms, the recommended dose of atrazine was used for 0, 1, and 2 years. We studied atrazine residues and enzyme activity in the soil, and phospholipid fatty acids (PLFA) were measured to study the structure of the soil microbiome. The results show that the rate of atrazine degradation occurred rapidly after the initial administration, and with the increase in continuous administration, its half-life decreased from 24.6 d in the first year to 14.1 d in the second year. The application of atrazine significantly affected soil urease activity and cellulase activity, but it had no significant effect on saccharase activity. The continuous application of atrazine had a significant effect on the biomass of cultured bacteria in soil, but not on the biomass of culturable fungi and actinomycetes in the soil. Furthermore, the results of PLFA analysis show that the application of atrazine had a significant effect on the microbial structure of the soil. These results indicate that the significant increase in the degradation rate of atrazine during continuous application is related to the high adaptability of the soil microbiome.
Purpose: Obesity is considered a risk factor for asthma exacerbation. However, limited studies have focused on the association of different levels of weight clusters with asthma. As such, we study the associations between different weight clusters with FeNO, blood eosinophils, and lung function among adult asthmatics.Methods: Data from 789 participants aged 20 years or older in the National Health and Nutrition Examination Survey 2007–2012 were analyzed. Body mass index (BMI) and waist circumference (WC) were used to determine the weight status. The study population was divided into five groups, including normal weight and low WC (153), normal weight and high WC (43), overweight and high WC (67), overweight and abdominal obesity (128), and general and abdominal obesity (398). A Multivariate linear regression model was used to evaluate the abovementioned associations after adjusting for potential confounding factors.Results: The adjusted models showed that general and abdominal obesity cluster (adjusted β = −0.63, 95% confidence interval (CI): −1.08, −0.17 p < 0.01), and the normal weight with high WC cluster (adjusted β = −0.96, 95% CI: −1.74, −0.19 p < 0.05) were associated with lower levels of blood eosinophils percentage than normal weight and low WC cluster. A similar tendency was shown in the levels of FeNO, but the differences were not significant (p > 0.05). Furthermore, abdominal obesity clusters were significantly associated with lower FVC, FVC% predicted, and FEV1 measures than normal weight and low WC cluster, especially those individuals with general and abdominal obesity cluster. No association was found between different weight clusters and FEV1/FVCF ratio. The two other weight clusters did not show the association with any of the lung function measures.Conclusion: General and abdominal obesity were associated with lung function impairment and a significant reduction of FeNO and blood eosinophil percentage. This study emphasized the importance of concurrent determination of BMI and WC in asthma clinical practice.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.